<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <link rel="stylesheet" href="./css/bootstrap.min.css">
    <link rel="stylesheet" href="./css/all.min.css">
    <link rel="stylesheet" href="./css/fontawesome.min.css">
    <link rel="stylesheet" href="./css/style.css">
    <title>Diabetes 360 eMagazine</title>
</head>
<body>


    <div class="container">
    <div class="main">
        <div class="left">
            <a href="./page-5.html"><img src="./img/prev.png" alt="previous"></a>
        </div>
        <div class="right">
            <a href="./page-7.html"><img src="./img/next.png" alt="next"></a>
        </div>
        
        <header class="pages-header-footer pages-h-f-white">
            <div class="row align-items-center m-0">
                <div class="col-3 header-txt header-txt-black"><p class=" m-0">NEWSLETTER in Diabetes</p></div>
                <div class="col-7 align-content-center"><div class="dark-line"></div></div>
                <div class="col-2"><img src="img/sanofi-logo-black.png" alt=""></div>
            </div>
        </header>
        <div class="article-head">
            <h1 class="headline"><span class="bold">Potential Value of Identifying Type 2 Diabetes
                Subgroups for Guiding Intensive Treatment:</span>
                A Comparison of Novel Data-Driven Clustering with
                Risk-Driven Subgroups</h1>
            <hr>
            <div class="subheader">
                <p class="primary-col">Source: Li X, van Giessen A, Altunkaya J, Slieker RC, Beulens JWJ, â€˜t Hart LM, Pearson ER, Elders PJM, Feenstra TL, Leal J. Potential
                    Value of Identifying Type 2 Diabetes Subgroups for Guiding Intensive Treatment: A Comparison of Novel Data- Driven Clustering with
                    Risk-Driven Subgroups. Diabetes Care. 2023 Jul 1;46(7):1395-1403. doi: 10.2337/dc22-2170.</p>
            </div>
        </div>
        <article>
            <div class="row">
                <div class="col-lg-6 col-sm-12">
                    <div class="feature-img">
                        <img src="./img/magazine-edit-13-3-17.jpg" alt="feature-img">
                    </div>
                    <p>Li et al aimed to estimate the impact on lifetime health
                        and economic outcomes of different methods of
                        stratifying individuals with type 2 diabetes, followed by
                        guideline-based treatment intensification targeting
                        BMI and LDL in addition to HbA<sub>1c</sub>.</p>
                        <p>
                            The authors divided 2,935 newly diagnosed individuals
from the Hoorn Diabetes Care System (DCS) cohort
into five Risk Assessment and Progression of Diabetes
(RHAPSODY) data-driven clustering subgroups (based
on age, BMI, HbA<sub>1c</sub>, C-peptide, and HDL) and four riskdriven
subgroups by using fixed cutoffs for HbA<sub>1c</sub> and
risk of cardiovascular disease based on guidelines.
                        </p>
                        <p>
                            The UK Prospective Diabetes Study Outcomes Model 2
estimated discounted expected lifetime complication
costs and quality-adjusted life-years (QALYs) for
each subgroup and across all individuals. Gains from
treatment intensification were compared with care
as usual as observed in DCS. A sensitivity analysis was
conducted based on Ahlqvist subgroups.
                        </p>
    
                </div>
    
                <div class="col-lg-6 col-sm-12">
                    <p>To help decision making, the authors expressed their
                        results as the maximum annual price in U.S. and U.K.
                        settings that can be spent in the health care sector for
                        identification and treatment of a certain subgroup while
                        remaining cost-effective.
                    </p>
                    <p>
                        This straightforward indicator informs clinicians and
decision makers on whether intensifying treatment
is beneficial and cost-effective. Under care as usual,
prognosis in the RHAPSODY data-driven subgroups
ranged from 7.9 to 12.6 QALYs. Prognosis in the risk-driven
subgroups ranged from 6.8 to 12.0 QALYs. Compared
with homogenous type 2 diabetes, treatment for
individuals in the high-risk subgroups could cost 22.0%
and 25.3% more and still be cost effective for data-driven
and risk-driven subgroups, respectively. Targeting BMI
and LDL in addition to HbA<sub>1c</sub> might deliver up to 10-fold
increases in QALYs gained.
                    </p>
                    <p>
                        Thus, the results showed that the data-driven subgroups
were able to stratify individuals with diverse prognosis,
displaying significant differences in simulated lifetime
QALYs and complication costs.
                    </p>
                    <p>
                        However, the risk-driven subgroups showed somewhat
larger differences between high- and low-risk subgroups
compared with the data-driven subgroups.
                    </p>
                    <div class="purple-quote primary-bg">
                        <div class="quotes"><img src="./img/quotes.png" alt=""></div>
                        <h3>Conclusion</h3>
                        <p>
                            Risk-driven subgroups better discriminated
prognosis. <br>
Both stratification methods supported
stratified treatment intensification, with
the risk-driven subgroups being somewhat
better in identifying individuals with the most
potential to benefit from intensive treatment.
Irrespective of stratification approach, better
cholesterol and weight control showed
substantial potential for health gains.
                        </p>
                    </div>
                    
                </div>
            </div>
            
            <div class="article-footer">
                <div class="row">
                    <div class="col-lg-6 col-sm-12">
                        <div class="ref-rating">
                            <p>
                                BMI, body mass index; HbA<sub>1c</sub>, hemoglobin A1c; LDL, low density lipoprotein;
HDL, high density lipoprotein; DCS, hoorn diabetes care system; QALYs,
quality-adjusted life-years
                            </p>                    
                        </div>
                        <div class="rating">
                            <p>How do you rate this article?</p>
                            <div class="row px-4">
                                <div class="col p-1"><a href="https://dta.eu.qualtrics.com/jfe/form/SV_efWbOu2lUz2aZpQ?CO=EG&Q_Language=EN&Brand=Unbranded&CN=Diabetes_360_eMagazine&Channel=E-NewsLetter&Function=Medical&Franchise=Diabetes_Core&TA=Diabetes&DA=Type_2_Diabetes&R=1" target="_blank"><img src="./img/red-1.png" alt="rate1"></a></div>
                                <div class="col p-1"><a href="https://dta.eu.qualtrics.com/jfe/form/SV_efWbOu2lUz2aZpQ?CO=EG&Q_Language=EN&Brand=Unbranded&CN=Diabetes_360_eMagazine&Channel=E-NewsLetter&Function=Medical&Franchise=Diabetes_Core&TA=Diabetes&DA=Type_2_Diabetes&R=2" target="_blank"><img src="./img/orange-2.png" alt="rate2"></a></div>
                                <div class="col p-1"><a href="https://dta.eu.qualtrics.com/jfe/form/SV_efWbOu2lUz2aZpQ?CO=EG&Q_Language=EN&Brand=Unbranded&CN=Diabetes_360_eMagazine&Channel=E-NewsLetter&Function=Medical&Franchise=Diabetes_Core&TA=Diabetes&DA=Type_2_Diabetes&R=3" target="_blank"><img src="./img/mustard-3.png" alt="rate3"></a></div>
                                <div class="col p-1"><a href="https://dta.eu.qualtrics.com/jfe/form/SV_efWbOu2lUz2aZpQ?CO=EG&Q_Language=EN&Brand=Unbranded&CN=Diabetes_360_eMagazine&Channel=E-NewsLetter&Function=Medical&Franchise=Diabetes_Core&TA=Diabetes&DA=Type_2_Diabetes&R=4" target="_blank"><img src="./img/yellow-4.png" alt="rate4"></a></div>
                                <div class="col p-1"><a href="https://dta.eu.qualtrics.com/jfe/form/SV_efWbOu2lUz2aZpQ?CO=EG&Q_Language=EN&Brand=Unbranded&CN=Diabetes_360_eMagazine&Channel=E-NewsLetter&Function=Medical&Franchise=Diabetes_Core&TA=Diabetes&DA=Type_2_Diabetes&R=5" target="_blank"><img src="./img/green-5.png" alt="rate5"></a></div>
                                <div class="col p-1"><a href="https://dta.eu.qualtrics.com/jfe/form/SV_efWbOu2lUz2aZpQ?CO=EG&Q_Language=EN&Brand=Unbranded&CN=Diabetes_360_eMagazine&Channel=E-NewsLetter&Function=Medical&Franchise=Diabetes_Core&TA=Diabetes&DA=Type_2_Diabetes&R=6" target="_blank"><img src="./img/turquoise-6.png" alt="rate6"></a></div>
                                <div class="col p-1"><a href="https://dta.eu.qualtrics.com/jfe/form/SV_efWbOu2lUz2aZpQ?CO=EG&Q_Language=EN&Brand=Unbranded&CN=Diabetes_360_eMagazine&Channel=E-NewsLetter&Function=Medical&Franchise=Diabetes_Core&TA=Diabetes&DA=Type_2_Diabetes&R=3" target="_blank"><img src="./img/aquamarine-7.png" alt="rate7"></a></div>
                            </div>
                            <div class="rating-bar">
                                <img src="./img/rating-1-5.png" alt="">
                            </div>  
                        </div>
                    </div>
                </div>
            </div>
        </article>
        </div>
        <footer class="footer">
            <div class="pages-header-footer">
                <div class="row">
                    <div class="col-1">
                        <div class="pagination">
                            <p>6</p>
                        </div>
                    </div>
                    <div class="col-8 align-content-center p-0">
                        <div class="dark-line"></div>
                    </div>
                    <div class="col-3 d-flex justify-content-center align-items-center">
                        <div class="header-txt-black header-txt">The 360 e-Magazine</div>
                    </div>
                </div>
            </div>
        
    </footer>

        </div>

    </div>    
    </div>


    <script src="./js/bootstrap.bundle.min.js"></script>
    </body>
</html>